MRK dividend yield: 3.25%. VZ dividend yield: 6.62%. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s. Verizon is America's largest wireless carrier by subscribers. The company offers a high current yield with modest dividend growth. Verizon's 5G network rollout and fiber expansion position it for steady cash flows. A defensive income stock with 19+ consecutive years of dividend increases.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Verizon is America's largest wireless carrier by subscribers. The company offers a high current yield with modest dividend growth. Verizon's 5G network rollout and fiber expansion position it for steady cash flows. A defensive income stock with 19+ consecutive years of dividend increases.
MRK currently offers a 3.25% yield (3.08/share/year) while VZ offers 6.62% (2.66/share/year). VZ provides higher current income. However, MRK has grown its dividend faster (8.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs VZ earn per year?
With $10,000 invested today: MRK pays approximately $325/year. VZ pays approximately $662/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $1,768/year (VZ).
Does MRK or VZ pay monthly dividends?
MRK pays quarterly dividends. VZ pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MRK vs VZ comparison by email
Save your analysis + get weekly dividend insights. Free forever.